KRN5500 in Treating Patients With Metastatic Solid Tumors

NCT00002923 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: KRN5500

Sponsor

Barbara Ann Karmanos Cancer Institute

Collaborators

[object Object]